Methenamine / sodium phosphate, monobasic Oral Tablet [Uroqid-Acid No.2]
RxNorm 368804
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 368804 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: methenamine / sodium phosphate, monobasic Oral Tablet [Uroqid-Acid No.2].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDFPrescribable
Semantic Branded Drug Form (SBDF):
Methenamine / sodium phosphate, monobasic Oral Tablet [Uroqid-Acid No.2]
(Atom ID: 12316666)
Patient Education
Methenamine
Methenamine, an antibiotic, eliminates bacteria that cause urinary tract infections. It usually is used on a long-term basis to treat chronic infections and to prevent recurrence of infections. Antibiotics will not work for colds, flu, or other viral infections. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.